HomeInsightsMarket Capitalization

Market Capitalization of Eris Lifesciences Ltd

Market Capitalization of Eris Lifesciences Ltd

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

1.2 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

ERIS Lifesciences Ltd

NSE: ERIS

MARKETCAP

₹ 17722.33 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of ERIS Lifesciences Ltd is ₹ 17722 crore as of 07 Nov 24.
  • The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8856 crore on March 2019 to ₹ 11442 crore on March 2024 . This represents a CAGR of 4.36% over 6 years. .
  • The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1302 as of 07 Nov 15:30.
  • The Dividend Payouts of ERIS Lifesciences Ltd changed from ₹ 2.87 to ₹ 7.35 over 4 quarters. This represents a CAGR of 156.10% .

Historical Market Cap of ERIS Lifesciences Ltd

No data available

* All values are in crore

Company Fundamentals for ERIS Lifesciences Ltd

No data available

Image

ERIS Lifesciences Ltd

NSE: ERIS

PRICE

₹ 1302.1

2.50 (0.19%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring ERIS Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20241302.1
06 Nov 20241299.6
05 Nov 20241311.35
04 Nov 20241316.6
01 Nov 20241347.7
31 Oct 20241321
30 Oct 20241287.7
29 Oct 20241307.35
28 Oct 20241279.9
25 Oct 20241293.2

SWOT Analysis Of ERIS Lifesciences Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for ERIS Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of ERIS Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of ERIS Lifesciences Ltd

No data available

No data available

Historical P/E Ratio of ERIS Lifesciences Ltd

No data available

* All values are in %

Historical Revenue of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of ERIS Lifesciences Ltd

No data available

* All values are in crore

Historical Dividend Payouts of ERIS Lifesciences Ltd

No data available

* All values are in

About ERIS Lifesciences Ltd

  • Eris Lifesciences Limited was incorporated on January 25, 2007.
  • Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
  • Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
  • The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
  • It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors.

ERIS Lifesciences Ltd News Hub

News

Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech

The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the exe...

Read more

25 Oct 202418:47

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

22 Oct 202415:56

News

ERIS Lifesciences to convene AGM

ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will...

Read more

05 Aug 202418:42

News

ERIS Lifesciences announces board meeting date

ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 2 August...

Read more

31 Jul 202412:40

News

Eris Lifesciences allots 22,492 equity shares under ESOP

Eris Lifesciences has allotted 22,492 equity shares under ESOP on 20 June 2024. The paid u...

Read more

24 Jun 202412:26

News

Board of ERIS Lifesciences approves composite scheme of arrangement

The Board of ERIS Lifesciences at its meeting held on 21 May 2024 has approved composite s...

Read more

21 May 202418:42

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for ERIS Lifesciences Ltd Market Cap

What is the market cap of ERIS Lifesciences Ltd?

As of November 8, 2024, ERIS Lifesciences Ltd has a market capitalization of ₹17722.33, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence ERIS Lifesciences Ltd's market capitalization?

ERIS Lifesciences Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of ERIS Lifesciences Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does ERIS Lifesciences Ltd's market capitalization change?

ERIS Lifesciences Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*